Alpha Architect High Inflation and Deflation (HIDE) News

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025...

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form 8-K - Current report

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates PR Newswire SAN DIEGO, May 7, 2024 Net...

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 PR Newswire SAN...

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City PR Newswire SAN DIEGO, April 11, 2024...

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference PR...

Biotech Finds Mid-Week Success Following Q4 Earnings Release

A California-based biotech company saw its shares soar on Wednesday, a day following the company’s Q4 earnings announcement. With analysts...